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Abstract
Objective: To evaluate adherence to uncomplicated urinary tract infections (UTI) guidelines and UTI diagnostic accuracy in
an emergency department (ED) setting before and after implementation of an antimicrobial stewardship intervention.
Methods: The intervention included implementation of an electronic UTI order set followed by a 2 month period of audit
and feedback. For women age 18 – 65 with a UTI diagnosis seen in the ED with no structural or functional abnormalities of
the urinary system, we evaluated adherence to guidelines, antimicrobial use, and diagnostic accuracy at baseline, after
implementation of the order set (period 1), and after audit and feedback (period 2).
Results: Adherence to UTI guidelines increased from 44% (baseline) to 68% (period 1) to 82% (period 2) (P#.015 for each
successive period). Prescription of fluoroquinolones for uncomplicated cystitis decreased from 44% (baseline) to 14%
(period 1) to 13% (period 2) (P,.001 and P= .7 for each successive period). Unnecessary antibiotic days for the 200 patients
evaluated in each period decreased from 250 days to 119 days to 52 days (P,.001 for each successive period). For 40% to
42% of cases diagnosed as UTI by clinicians, the diagnosis was deemed unlikely or rejected with no difference between the
baseline and intervention periods.
Conclusions: A stewardship intervention including an electronic order set and audit and feedback was associated with
increased adherence to uncomplicated UTI guidelines and reductions in unnecessary antibiotic therapy and
fluoroquinolone therapy for cystitis. Many diagnoses were rejected or deemed unlikely, suggesting a need for studies to
improve diagnostic accuracy for UTI.
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Introduction
Acute uncomplicated cystitis and pyelonephritis are common
indications for prescription of antimicrobials in healthy, non-
pregnant women [1]. Guidelines for the treatment of these
conditions were first published by the Infectious Diseases Society
of America (IDSA) in 1999[2]. Several studies subsequently
documented that prescribing practices for uncomplicated urinary
tract infection (UTI) varied widely and adherence to these and
other UTI guidelines was often low [3–13]. The updated IDSA
and European Society for Microbiology and Infectious Diseases
guidelines published in 2011 emphasize the importance of local
susceptibility data and the ecological adverse effects of antimicro-
bial therapy, including antimicrobial resistance and Clostridium
difficile infection [14]. Ecological effects merit particular consider-
ation in treatment of cystitis because there is minimal risk of
progression to severe illness and infection may resolve in 25% to
42% of women who are not treated or who are treated with a drug
without in vitro activity against the uropathogen [14–16]. As in the
1999 guidelines, the updated guidelines continue to recommend
that in areas in which trimethoprim-sulfamethoxazole (TMP-
SMX) resistance rates for uropathogens causing acute uncompli-
cated cystitis do not exceed 20%, TMP-SMX for 3 days is
recommended as a first line option. Fluoroquinolones for 3 days
are recommended as a second line option for treatment of cystitis
due to their adverse ecological effects [17]. The updated guidelines
are more specific in recommending that nitrofurantoin for 5 days
or a single dose of fosfomycin should also be considered as first line
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options for treatment of cystitis. Fluoroquinolones remain a first
line option for pyelonephritis; however the updated guidelines
more specifically recommend a 7 day fluoroquinolone regimen as
opposed to a 7–14 day regimen.
In a recent commentary, May et al. [18] issued a call to action
for research to address the large gap in the literature evaluating
ED-based antimicrobial stewardship strategies. Uncomplicated
UTIs are often diagnosed and treated in the emergency
department (ED), [19] however, we are unaware of data on
adherence to UTI guidelines or on the effect of antimicrobial
stewardship interventions for UTI in this setting. Moreover, some
studies have provided evidence that the accuracy of UTI diagnoses
may be suboptimal in the ED [20–23]. For example, Shapiro et al.
[20] found that 43% of patients with traditional UTI symptoms
had negative urine cultures. Huppert et al. [22] demonstrated that
53% of adolescent women with a final diagnosis of a UTI had a
sexually transmitted infection.
Here, we assessed adherence to guidelines for management of
uncomplicated UTI in an urban ED before and after initiation of a
stewardship intervention that included implementation of an
electronic order set followed by audit and feedback. We also
assessed UTI diagnostic accuracy before and after the interven-
tion. We hypothesized that increased adherence to the guidelines
would reduce unnecessary days of antibiotic therapy for UTI and
reduce the use of fluoroquinolones for uncomplicated cystitis
without increasing adverse events or the frequency of treatment
failure. We also hypothesized that UTI diagnostic accuracy would
improve after audit and feedback.
Methods
Study design and setting
We conducted a before and after study between 2010 and 2012
at MetroHealth Medical Center. MetroHealth Medical Center is
an academic urban level 1 trauma center averaging 90,000–
100,000 ED visits annually of which approximately 200–300 visits
per month include any UTI- associated diagnosis, including both
uncomplicated and complicated UTIs. The ED at our institution
began using an electronic medical record (EMR), EPICH system,
in 1999.
Ethical approval
The study was conducted in accordance with the Declaration of
Helsinki and was approved by the MetroHealth Medical Center’s
Institutional Review Board. The Institutional Review Board
provided a waiver of the requirement for informed consent as
the intervention was deemed to be a quality improvement
initiative that involved minimal risk to subjects and no procedures
for which written consent would normally be required outside of
the research context, the study would not have been feasible
without the waiver of consent, and subject medical record review
was conducted retrospectively.
Selection of study patient visits for retrospective review
Potential study patient visits were identified using the following
International Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) codes for UTIs: 599.0 for UTI, 595.9 for cystitis, and
590.10 for pyelonephritis. Patient visits for women between the
ages of 18 and 65 were randomly selected for review using
computer-generated randomization (www.random.org) during
twelve specified months over a 3 year time period (2010 –
2012). Patient visits for women with any of the following
characteristics were excluded from the study: pregnancy, known
significant structural or functional urological abnormalities,
urinary tract instrumentation within the preceding 7 days,
residency in a skilled nursing facility, inability to give a history,
or currently on suppressive antibiotic therapy to prevent UTIs.
Patients with diabetes were included unless they had diabetes that
was poorly controlled, defined for the purposes of this study as
having a hemoglobin A1C greater than 8. Patients with a history
of kidney stones were included unless stones were documented to
be present at the time of the ED visit. Two hundred patient visits
(50 during each of 4 specified months February, March,
November, and December 2010) before any intervention (base-
line), 200 patient visits (50 during each of 4 specified months
February, March, September, October 2011) after the electronic
order set intervention (period 1), and 200 patient visits (50 during
each of 4 specified months February, March, September, October
2012) after the audit and feedback intervention (period 2) meeting
inclusion criteria were included in the study.
Data collection
Demographic and clinical data were abstracted from the
electronic medical record by three of the authors (CJF, MTH,
and AHS) using a standardized data collection form with detailed
instructions on how each variable was defined. Each chart was
reviewed at least twice for accuracy of data collection. Provider
determined UTI diagnoses were based on the ICD-9-CM codes
(both primary and secondary) attached to the visit by hospital
coders and on provider documentation. The nonspecific UTI
diagnosis code 599.0 was commonly used and thus determination
had to be made whether the case represented cystitis or
pyelonephritis as treatment choice and duration were dependent
on the specific urinary tract syndrome being treated. Based on
proposed classification systems in the literature [24,25], provider
determined UTI diagnoses with the nonspecific 599.0 code were
classified as cystitis if there was no documentation of fever, flank
pain or costovertebral angle tenderness, if the note specifically
stated that no evidence for pyelonephritis was present, or if the
presence of fever, flank pain or costovertebral angle tenderness was
attributed to another condition. If fever or flank pain was present
without documentation of an alternative diagnosis for these signs
or symptoms, then the visit was classified as pyelonephritis.
Patients’ medical records were reviewed for 8 weeks following
the ED visit to evaluate for treatment failure and for adverse
events related to treatment. Treatment failure was defined as a
change in the initially prescribed UTI treatment regimen within 2
weeks of prescription due to clinical failure, isolation of a resistant
organism, or adverse effects. Primary adverse events included
allergic reactions, gastrointestinal side effects, and vaginal yeast
infections occurring within 8 weeks of treatment and deemed to be
related to the antibiotic prescribed for UTI. Other adverse events
included return visits to the ED or other hospital sites for
persistence of UTI symptoms or for additional treatment for
alternative diagnoses related to UTI symptoms, missed STI
diagnoses, or for treatment of a recurrent UTI (separate from
initial UTI) occurring within 8 weeks of the initial ED visit. For
diagnostic accuracy, patients were classified as having definite/
probable, possible, unlikely, and rejected diagnoses of UTI based
on defined criteria (Table S1). Questionable classifications were
resolved by a second reviewer.
Electronic order set intervention (period 1)
In December 2010, recommendations for management of
uncomplicated UTIs, based on the anticipated updated IDSA
and European Society for Microbiology and Infectious Diseases
guidelines [14] (subsequently published in March 2011), were
reviewed with three key ED personnel. Electronic versions of the
UTI Stewardship in an Emergency Department Setting
PLOS ONE | www.plosone.org 2 February 2014 | Volume 9 | Issue 2 | e87899
IDSA and European Society for Microbiology and Infectious
Diseases guidelines were sent to the three key ED personnel after
they were published. From our institution’s traditional antibio-
gram, which reports organism susceptibility data from the first
isolate per patient per year from any anatomic site and any
hospital site (both inpatient and outpatient), the overall rate of
Escherichia coli resistance to TMP-SMX was 19%, less than the
20% threshold for including TMP-SMX as a first line therapy for
uncomplicated cystitis [14]. Therefore, 3 days of TMP-SMX or 5
days of nitrofurantoin was recommended as first line therapy for
uncomplicated cystitis. The institution at which this study occurred
serves an indigent population. Fosfomycin was not included as a
primary treatment option due to its expense and due to the fact
that Escherichia coli susceptibility rates to nitrofurantoin at our
institution are high. A 3 day course of ciprofloxacin was reserved
for patients in whom both TMP-SMX and nitrofurantoin were
contraindicated. Contraindications to TMP-SMX or nitrofuran-
toin included significant allergies or intolerances or a urine culture
within the last year with an organism that was resistant to both
TMP-SMX and nitrofurantoin.
The recommended treatment regimen for pyelonephritis was
ciprofloxacin for 7 days or TMP-SMX for 10 – 14 days. There was
no formal recommendation for an initial IV dose; however a
recommendation for a urine culture in cases of pyelonephritis was
included. A UTI electronic order set including these recommen-
dations was created and made available for use on December 30,
2010 (Figure S1 provides a screen shot of the electronic order set).
ED personnel were informed of the order set by the ED
department chair and the physician responsible for medical
informatics for the ED.
The ED had a pre-existing policy in place for providing small
financial incentives to faculty providers based on their compliance
with several quality indicators. Although not part of our
stewardship initiative, in April 2011, three months after the
implementation of the order set and after collection of the first two
period 1 data points, ED personnel decided to include use of the
UTI order set as one of their quality indicators. Financial incentive
checks related to use of the order set were first received in August
2011.
Audit and feedback intervention (period 2)
From November 14, 2011 until January 16, 2012 we performed
an audit and feedback intervention, in which charts of women
meeting study eligibility as described previously were reviewed. A
pharmacist (AS) reviewed the cases and discussed them with the
ID physician (MH). This required approximately 1.5–3 hours of
pharmacist time and 30 minutes of physician time per day
(Monday through Friday). Feedback for individual patient visits
was given to providers via staff messages in the EMR within 5–7
days of the ED visit if the recommended UTI medication choice or
duration of therapy was not used, if urine cultures were not sent in
cases of suspected pyelonephritis, or if the UTI diagnosis was
determined to be unlikely or rejected by defined UTI study
criteria. An educational lecture about UTIs was given to the ED
physicians on January 18, 2012. Information presented included a
detailed review of the IDSA and European Society for Microbi-
ology and Infectious Diseases treatment guidelines, definitions for
various UTI syndromes including uncomplicated vs. complicated
UTIs and asymptomatic bacteriuria, data from the baseline and
period 1 time periods, and examples of cases that we defined as
unlikely or rejected.,
Outcome measures
The primary outcome was overall adherence to guidelines for
management of uncomplicated UTI, both to medication choice
and duration of therapy. Secondary outcomes included total and
unnecessary days of antibiotic therapy for UTI, use of fluoro-
quinolones for uncomplicated cystitis, treatment failure, adverse
events, and diagnostic accuracy.
Statistical analysis
Data were analyzed with the use of STATA 11 (StataCorp). We
compared the baseline with period 1 and period 1 with period 2
using unpaired Student t- and Kruskal-Wallis tests for normally-
and non-normally distributed data, respectively. The Pearson Chi-
square test and Fisher’s exact tests were used for categorical data
as indicated.
Results
Characteristics of study subjects
There were no significant differences in patient characteristics
between baseline, period 1, and period 2 (Table 1). Overall, 66%
to 74% of visits were classified as cystitis. During the 3 time
periods, patients were assessed by 32, 37, and 40 different
providers, respectively. During the 2 months of audit and
feedback, 127 patient visits meeting inclusion criteria were
reviewed. Sixty seven recommendations were made for 51 patient
visits (40%). Types of recommendations given included: 16 (24%)
for alternate medication choice, 11 (16%) for alternate duration of
therapy, 7 (11%) for urine culture for pyelonephritis, and 33 (49%)
for diagnosis unlikely/rejected.
Adherence to guidelines
Overall adherence to UTI treatment recommendations with
regard to both antibiotic choice and duration of therapy at
baseline and during the intervention periods is shown in Figure 1.
In comparison to baseline, after implementation of the electronic
order set (period 1) overall adherence to recommended UTI
treatment regimens increased from 44% to 68% (P,.001),
adherence to the recommended antibiotic choice increased from
70% to 89% (P,.001), and adherence to the recommended
duration of treatment improved from 62% to 75% (P= .005).
There was no difference in adherence during period 1 before
versus after the financial incentive was added for use of the order
set (67% versus 69%; P= .88).
In comparison to period 1, after audit and feedback overall
adherence to treatment guidelines increased further from 68 % to
82% (P= .015), that was attributable to increased adherence to the
recommended duration of treatment from 75% to 88% (P= .017).
Adherence to recommended antibiotic choice was similar in
periods 1 and 2 (89% and 90%, respectively; P= .74).
In comparison to the baseline period, there was a significant
increase in the percentage of urine cultures sent for cases of
suspected pyelonephritis during the combined intervention periods
(25/67, 37% versus 70/121, 58%, respectively; P= .007). There
was no increase in the percentage of urine cultures sent for cases of
suspected cystitis during the intervention periods (36/133, 27%
versus 71/278, 26%, respectively; P= .74).
Antimicrobial use
In comparison to baseline, after implementation of the
electronic order set (period 1), unnecessary UTI days of therapy
for the 200 patients evaluated in each period decreased from 250
unnecessary days to 119 unnecessary days (P,.001), prescription
of fluoroquinolones for uncomplicated cystitis decreased from 44%
UTI Stewardship in an Emergency Department Setting
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to 14% (P,.001), and the average duration of TMP-SMX or
ciprofloxacin therapy for cystitis decreased from 5.6 days at
baseline to 3.9 days (P,.001) (Table 2).
In comparison to period 1, after audit and feedback, unneces-
sary UTI days of therapy for the 200 patients evaluated decreased
significantly further to 52 unnecessary days (P,.001), prescription
of fluoroquinolones for uncomplicated cystitis remained relatively
stable at 13% (P= .70) and the average duration of TMP-SMX or
ciprofloxacin therapy for cystitis decreased from 3.9 to 3.6 days
(P= .17) (Table 2).
Table 1. Patient characteristics by study time period.
Baseline Period 1 Period 2 P value
Characteristic n = 200 n = 200 n = 200 Baseline– period 1
Period 1-
period 2
Age, median, (IQR 25–75) 30 [22–43] 27 [21–43] 30 [ 22–42] .66 .75
Age . 50 25 (12.5) 28 (14.0) 23 (11.5) .66 .45
Ethnicity Black 69 (34.5) 74 (38.0) 57 (28.5) .60 .07
Hispanic/Latino 18 (9.0) 27 (13.9) 24 (12.0) .15 .65
White 83 (41.5) 83 (42.6) 57 (28.5) 1.00 .006
Diabetes 12 (6.0) 13 (6.5) 10 (5.0) .84 .52
Renal conditionsa 21 (10.5) 23 (11.5) 17 (8.5) .75 .32
History of STIb 47 (23.5) 52 (26.0) 62 (31.0) .56 .27
Post-menopausalc 26 (13.0) 25 (12.5) 21(10.5) .40 .27
Hospitalization within the past 12 months 30 (15.0) 22 (11.0) 20 (10.0) .31 .57
Antibiotic use within the past 12 months Any 97 (48.5) 103 (51.5) 100 (50.0) .55 .76
Trimethoprim-
sulfamethoxazole
28 (14.0) 35 (17.5) 39 (19.5) .34 .61
Ciprofloxacin 34 (17.0) 29 (14.5) 20 (10.0) .49 .17
Nitrofurantoin 8 (4.0) 16 (8.0) 15 (7.5) .09 .85
Diagnosis Cystitis 133 (66.5) 131 (65.5) 148 (74.0) .83 .06
Pyelonephritis 67 (33.5) 69 (34.5) 52 (26.0) .83 .06
Data are no. or proportion (%) of patients, unless otherwise indicated.
aRenal conditions include history of kidney stones, recent acute or chronic kidney disease, urinary incontinence with or without previous surgery for this condition.
bSTI, sexually transmitted infection.
cDocumented post-menopausal status or age . 50 if status not documented.
doi:10.1371/journal.pone.0087899.t001
Figure 1. Percentage of cases adherent to UTI guidelines at baseline and during the tiered stewardship intervention. The percentages
in the boxes are the average of the 4 time points during each period.
doi:10.1371/journal.pone.0087899.g001
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Treatment failures and adverse outcomes
Treatment failure occurred in 11%, 7%, and 8% of patients
reviewed during the baseline period, period 1, and period 2,
respectively (P $.16 for each comparison). A primary adverse
event of either allergic reaction, gastrointestinal side effect, or
vaginal yeast infection occurred in 6%, 8%, and 10% of patients
reviewed during the baseline period, period 1, and period 2,
respectively (P $.59 for each comparison). Other adverse events
occurred in 24%, 27%, and 24% of patients reviewed during the
baseline period, period 1, and period 2, respectively (P$.52 for
each comparison) (Table 2). Although not included as an outcome,
antimicrobial resistance rates for Escherichia coli obtained from the
institution’s traditional antibiogram over the time period of the
study 2010, 2011 and 2012 to TMP-SMX were 19%, 20%, and
21%, to nitrofurantoin were 5%,7%, and 9% and for ciprofloxacin
were 16%, 16%, and 16% respectively.
Diagnostic accuracy
Forty percent, 42%, and 41% of cases diagnosed as UTI by
clinicians were classified as unlikely or rejected cases of UTI
during the baseline period, period 1, and period 2, respectively (P
$.37 for each comparison) (Figure 2). Examples of cases classified
as unlikely or rejected are described in Table 3. Most unlikely or
rejected cases had more than one reason to be classified as such.
For 245 total cases deemed unlikely or rejected, the reasons they
were deemed unlikely or rejected included: 126 (51%) in which
patients reported having no urinary symptoms, 50 (20%) had a
definite genital tract infection; 59 (24%) had vaginal symptoms
attributed to either a genital tract infection for which testing was
not done or a non-infectious genital tract syndrome, 47 (19%) had
no documentation of urinary symptoms, 10 (4%) had a definite
non-genital tract infection to explain the symptoms, 69 (28%) had
a probable non-genital tract alternative diagnosis. Urine cultures
were done in 40 (16%) cases and all were negative. Negative
urinalyses with no urine culture performed occurred in 19 (8%)
cases. No improvement despite adequate therapy was seen in 3
(1%) patients.
Discussion
We demonstrated that a stewardship intervention that included
implementation of an electronic order set followed by a period of
audit and feedback was associated with a sustained improvement
in adherence to uncomplicated UTI guidelines. These findings
have important implications for several reasons. First, the
improvement in adherence to guidelines was achieved through a
simple intervention that required minimal resources. Because the
EPICH EMR system is widely used, similar order sets could be
instituted in many other U.S. healthcare facilities. Second, because
UTI is one of the most common indications for prescription of
antimicrobials, improving management of this condition should be
a focus of stewardship programs. Our intervention reduced both
unnecessary antibiotic days of therapy for UTI and fluoroquin-
olone use for cystitis. Reducing overuse of fluoroquinolones is an
important goal due to their propensity to cause adverse ecological
effects and due to rising rates of resistance to these agents [26].
Finally, the improvement in adherence to UTI guidelines was
achieved without any apparent increase in treatment failures or
adverse events.
Despite the increase in adherence to UTI treatment guidelines,
it is notable that there was no improvement in UTI diagnostic
accuracy during the intervention. For 40% to 42% of cases
diagnosed as UTI by clinicians, the diagnosis was deemed unlikely
or rejected, consistent with previous studies [20–23]. The lack of
improvement in diagnostic accuracy with the audit and feedback
intervention may have been in part due to its relatively short
duration (2 months) and that the feedback was not given in real
time. However, it is likely that diagnostic accuracy is more difficult
to improve as compared to choosing the appropriate medication
and duration of therapy.
One strategy to optimize diagnostic accuracy might be to
improve use and interpretation of the urinalysis. In our ED, the
protocol followed by the triage nurses requires a urinalysis to be
performed in any woman presenting with abdominal pain, urinary
tract symptoms, genital tract symptoms, or fever. Based upon
clinical documentation and discussion with ED providers during
audit and feedback, treatment of UTI cases classified as unlikely or
rejected was often driven by the finding of a ‘‘dirty urine’’ (i.e.,
abnormal urinalysis). Patients who did not have symptoms
suggestive of a UTI or who had alternative explanations for their
Table 2. Antibiotic use, treatment failures, and adverse events for study patients at baseline and during intervention Period 1 and
Period 2.
P value
Outcome
Baseline
N=200
Period 1
N=200
Period 2
N=200 Baseline-Period 1 Period 1-Period 2
Mean duration of therapy for cystitisa (days) 5.6 3.9 3.6 ,.001 .17
Percentage of fluoroquinolone regimens for cystitis 44.4 14.5 12.9 ,.001 .70
Unnecessary antibiotic days of therapy, total 250 119 52 ,.001 ,.001
Treatment failureb 22 (11.0) 14 (7.0) 17 (8.5) .16 .58
Primary adverse eventsc 12 (6) 17 (8.5) 19 (9.5) .66 .59
Other adverse eventsd 49 (24.5) 54 (27) 47 (23.5) .54 .52
aIncluding only trimethoprim-sulfamethoxazole and ciprofloxacin containing regimens.
bA change in the initially prescribed UTI treatment regimen within 2 weeks of prescription due to clinical failure, isolation of a resistant organism, or adverse effects.
cIncluding allergic reactions, gastrointestinal side effects, and vaginal yeast infections occurring within 8 weeks of treatment and felt to be related to the antibiotic
prescribed for UTI.
dIncluding return visits to the ED or other hospital sites for persistence of UTI symptoms or for additional treatment for alternative diagnoses related to UTI symptoms,
missed STI diagnoses, or for treatment of a recurrent UTI (separate from initial UTI) occurring within 8 weeks of the initial ED visit.
doi:10.1371/journal.pone.0087899.t002
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Figure 2. Percentage of cases deemed unlikely or rejected at baseline and during the tiered stewardship intervention. The
percentages in the boxes are the average of the 4 time points during each period.
doi:10.1371/journal.pone.0087899.g002
Table 3. Examples of cases diagnosed as urinary tract infection by providers, but classified as unlikely or rejected based on
medical record review.
Description Classification Reason for classification
20 year old woman diagnosed with genital herpes infection one day ago presented with continued
dysuria and difficulty urinating despite acyclovir treatment. Tender genital ulcers on exam. Urinalysis
(UA) with 30–100 white blood cells (WBC) per high power field and nitrite negative. Diagnosed with
urinary retention due to primary herpes infection and UTI and prescribed 7 days of ciprofloxacin.
Urine culture negative.
Rejected Definite alternative diagnosis and
negative urine culture
19 year old woman presented with suicidal ideation. No urinary symptoms, but UA ordered due to
mild leukocytosis (13,500 WBC/mL) and because Psychiatry recommended ruling out infection.* UA with
negative nitrite, positive leukocyte esterase, 30–100 WBC and 10–30 squamous epithelial cells per high
power field. Diagnosed with depression with suicidal ideation and UTI and prescribed 3 days of
trimethoprim-sulfamethoxazole. No urine culture sent. The patient was diagnosed with chlamydia 5
months later.
Unlikely No urinary symptoms
21 year old with motor vehicle accident 2 months ago presented with lower back pain exacerbated by
movement and right foot numbness. No urinary symptoms or fever. UA with negative blood and nitrite,
10–30 WBC and 10–30 squamous epithelial cells per high power field. Diagnosed with acute lumbar strain
and UTI and prescribed 7 days of nitrofurantoin. No urine culture sent.
Unlikely Probable alternative diagnosis
and no significant
urinary symptoms
65 year old post-menopausal woman presented with heavy vaginal bleeding, but no urinary symptoms
or fever. On exam a mass was noted protruding from the cervical os. Clean catch UA with large blood,
large leukocyte esterase, positive nitrite, 10–30 WBC and 2–5 squamous epithelial cells per high power
field. Diagnosed with vaginal bleeding (suspected cervical cancer) and UTI based on abnormal UA and
prescribed 5 days of nitrofurantoin. Straight catheterization urine culture negative.
Rejected Vaginal symptoms and definitive
alternative diagnosis. Urine
culture negative.
33 year old woman presented with epigastric burning pain, nausea and vomiting. No urinary symptoms,
fever, or flank pain. Mild epigastric tenderness on exam. UA with negative blood, positive nitrite, small
leukocyte esterase, 2–5 WBC and 30–100 squamous epithelial cells per high-power field. Diagnosed with
dehydration and UTI and prescribed 7 days ciprofloxacin. No urine culture sent.
Unlikely Probable alternative diagnosis
(GI) and no urinary symptoms
33 year old woman presented with fever, cough, headache, myalgias, back pain, and sick contacts with
similar illness. No urinary symptoms. On exam, temperature was 38.5 uC. There was neither abdominal
tenderness nor costovertebral angle tenderness. UA not done, but the provider listed abnormal findings
from a UA from 6 months earlier with pyuria (10–30 WBC per high power field). Diagnosed with viral
syndrome and UTI and prescribed trimethoprim-sulfamethoxazole for 3 days.
Unlikely Probable alternative diagnosis
(influenza-like illness during
influenza season)
*Interviews with Emergency Department providers suggested that Psychiatry personnel recommended sending a UA to rule out ‘‘infection’’ in anyone presenting with
psychiatric illness.
doi:10.1371/journal.pone.0087899.t003
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symptoms (e.g. genital tract infections) were often treated for a
UTI solely on the basis of an abnormal urinalysis.
Our findings add to previous reports of interventions that
resulted in improved adherence to UTI guidelines in ambulatory
clinic settings [27–30]. The two studies performed in the United
States were published over 10 years ago prior to the IDSA UTI
guidelines [27,28]. These studies included select groups of patients
with a high likelihood of cystitis, demonstrated improvement
primarily through nurse driven protocols either over the telephone
or at an office visit, focused on reducing lab testing for
uncomplicated cystitis, and alluded to but did not fully assess the
problem of overdiagnosis of UTI. Although Saint et al. [27]
evaluated a large number of patients, the data was reviewed on a
population level without review of individual patient information.
These studies also involved significant educational components
with multiple meetings and ancillary tools. In contrast to previous
studies, our study describes a more ‘‘real world’’ view of the
management of uncomplicated UTIs (both cystitis and pyelone-
phritis) that was effective in changing physician behavior. We did
not focus on reducing lab testing for cystitis but instead on
improving testing for pyelonephritis and we assessed the significant
problem of overdiagnosis of UTI. We also utilized the electronic
medical record to implement our intervention with few additional
ancillary efforts. Our study also was performed in an ED setting as
compared to ambulatory clinic settings in the previous studies.
Finally, in contrast to our findings, Flottorp et al. [29] found that a
multi-faceted intervention that included computer based decision
support had little effect in improving adherence to UTI treatment
guidelines.
Our study has several limitations. First, the study was conducted
at a single institution and the intervention was specific to the
department workflows (frequent use of electronic order sets) and
patient population (urban population with high rates of sexually
transmitted infections) of that institution. Other approaches may
be better suited to different institutions or departments. Second, it
is not clear if the small financial incentive for use of order sets
contributed significantly to the success of the intervention.
However, within period 1 there was no difference in adherence
to the guidelines before versus after the financial incentive was
implemented. Third, urine cultures were not routinely performed
as part of the evaluation for suspected UTI. Thus, determination
regarding diagnostic accuracy was often dependent on urinalysis
results and documentation of signs and symptoms. Fourth, the
criteria we used to determine diagnostic accuracy have not yet
been validated. Fifth, we did not provide definitions for
uncomplicated vs. complicated UTIs in the electronic order set
and did not evaluate ED visits for patients with complicated UTIs
to determine if they were treated inappropriately as uncomplicated
UTIs. Finally, the use of ICD9 codes could overestimate or
underestimate the diagnosis of UTI since it is dependent on the
hospital coder; however no changes in the coders or how they
apply the codes were made during the study period and thus
although the absolute numbers may be over or under-estimated,
the same rate of over and under-estimation would be assumed to
occur over time and thus the trends seen would most likely not be
related to changes in over or under-estimation
In summary, an antimicrobial stewardship initiative for
uncomplicated UTI was associated with a significant and sustained
improvement in adherence to treatment guidelines, a decrease in
unnecessary antibiotic therapy for UTIs, and a reduction in the
use of fluoroquinolone containing regimens for uncomplicated
cystitis. There was no increase in UTI treatment failures or
adverse events. Future studies are needed both to determine the
effect of this intervention on rates of antimicrobial resistance in
uropathogens and to identify effective strategies to reduce the
frequency of prescription of UTI therapy for patients who are
unlikely to have UTIs.
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